Still reeling from an accounting scandal, the Japanese company feels pressured to sell off one of the few bright spots in the company: its medical division. The sale could be worth billions of dollars.
from EETimes: http://ift.tt/1Tb2JUC
via Yuichun
沒有留言:
張貼留言